Hershey Foods Price Target is Raised and 3 More Analyst Notes to Glance At
Stock upgrades and downgrades are a controversial part of Wall Street. Despite regulations, many banks and firms still have a positive bias toward current clients and companies desired as future clients. In addition, Wall Street analysts are straight-up biased to the buy side. The percentage of sell recommendations is normally below 15 percent!
Regardless, upgrades and downgrades move stocks in the short-term. They fall into our CHEAT SHEET framework category ‘C = Catalyst for a Stock?s Movement’. Here are catalysts you must know today:
Biomarin Pharm (NASDAQ:BMRN): Barclays reiterated its rating of Overweight for this company and changed its price target from $54 to $70.